Recalls And Multiple Market Challenges Test Philips’ Resilience Into Q1

Philips’ revenues contraction in the first quarter of 2022 was less than feared and its order book remains impressive, but challenges presented by the recall program and generic post-COVID factors for the year ahead remain substantial.

alamy

The dip in Philips' first-quarter sales ̶ down 4% year-over-year to €3.9bn ($4.2bn) ̶ was not as sharp as the high-single digits drop projected in earlier guidance but reflects the tough set of business circumstances the company faces, according to CEO Frans van Houten 

Chief among these challenges is the ongoing recall associated with Respironics’ ventilators, announced in 2021. Extrapolating current trends in...

More from Business

More from Medtech Insight

Finland Cracks Down On Software That Needs Regulating As A Medical Devices

 

Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it. 

Milner Pitch Day: Multiomic Pathology, Microcancer Avatars And Cell Morphology Intelligence

 

The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.

Investors Urged To Prioritize Patient Engagement To Ensure Clients’ Products Succeed

 

To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.